CIK 0000021665
- Large accelerated filer
COLGATE PALMOLIVE CO
Sign in to watch- Ticker
- CL
- Exchange
- NYSE
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 131815595
- Phone
- +1 212-310-2000
- Business address
- 300 PARK AVE, NEW YORK, NY, 10022
- Former names
- COLGATE PALMOLIVE CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,027,828
- in 6 filings
Net −$8,027,828. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Tsourapas Panagiotis −$2.9M COO, CD, EMEA, APac, Skin sold 77% of stake
- Hazlin John −$2.3M Chief Growth Officer sold 46% of stake
- Wallace Noel R. −$2.0M Chairman, President & CEO sold 5% of stake
- NORRINGTON LORRIE M −$414K Director sold 9% of stake
- Malcolm Gregory −$402K EVP and Controller sold 29% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | Hazlin John Chief Growth Officer | Option exercise | +23,376 | $77.04 | $1.8M | 50,397 |
| 2026-11-04 | Hazlin John Chief Growth Officer | Sale | −23,376 | $99.15 | $2.3M | 27,021 |
| 2026-11-04 | Hazlin John Chief Growth Officer | Option exercise · Stock Option (Right to Buy) | −23,376 | 0 | ||
| 2026-09-16 | Hazlin John Chief Growth Officer | Grant or award | +3,908 | 27,021 | ||
| 2026-09-16 | Hazlin John Chief Growth Officer | Grant or award · Stock Option (Right to Buy) | +27,042 | 27,042 | ||
| 2026-09-13 | Hazlin John Chief Growth Officer | Shares withheld for taxes | −499 | $86.80 | $43K | 23,113 |
| 2026-09-12 | Hazlin John Chief Growth Officer | Shares withheld for taxes | −439 | $86.80 | $38K | 23,612 |
| 2026-09-11 | Hazlin John Chief Growth Officer | Shares withheld for taxes | −649 | $86.80 | $56K | 24,051 |
| 2026-02-23 | Hazlin John Chief Growth Officer | Grant or award | +12,803 | 30,539 | ||
| 2026-02-23 | Hazlin John Chief Growth Officer | Shares withheld for taxes | −6,117 | $97.10 | $594K | 24,422 |
| 2026-02-10 | Hazlin John Chief Growth Officer | Option exercise | +20,989 | $76.41 | $1.6M | 38,634 |
| 2026-02-10 | Hazlin John Chief Growth Officer | Sale | −20,989 | $94.25 | $2.0M | 17,645 |
| 2026-02-10 | Hazlin John Chief Growth Officer | Option exercise · Stock Option (Right to Buy) | −20,989 | 0 | ||
| 2025-12-03 | Hazlin John Chief Growth Officer | Shares withheld for taxes | −156 | $78.20 | $12K | 17,645 |
| 2025-09-13 | Hazlin John Chief Growth Officer | Shares withheld for taxes | −449 | $83.28 | $37K | 17,629 |
| 2025-09-12 | Hazlin John Chief Growth Officer | Shares withheld for taxes | −377 | $83.28 | $31K | 18,078 |
| 2025-09-11 | Hazlin John Chief Growth Officer | Grant or award | +4,045 | 18,455 | ||
| 2025-09-11 | Hazlin John Chief Growth Officer | Grant or award · Stock Option (Right to Buy) | +28,007 | 28,007 |
Page 1 of 1 · 18 trades